Search PubMed⌕ Search

PubMed · 9255249

[Psoriasis today].

Abstract

PATHOGENESIS: Psoriasis is a proliferative disease of the epiderm which leads to major disorders in keratinocyte differentiation. The pathogenesis remains largely unknown. It has been hypothesized that intrinsic alterations of the keratinocyte or local or general immune disorders could be involved. GENES IMPLICATED: Psoriasis is a genodermatosis which is revealed or aggravated by environmental factors. The nature and chromosomal localization of the genes involved is currently under study. LOCAL TREATMENT: Over the last years, use of vitamin D has largely replaced former topical corticosteroid therapy. Phototherapy using narrow spectrum ultraviolet B is currently the standard treatment for extensive psoriasis. GENERAL TREATMENT: Methotrexate, retinoids and cyclosporin are effective in severe psoriasis but have side effects which limit their indications.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J Guilhou. 1997-07-12. [Psoriasis today].. https://pubmed.ncbi.nlm.nih.gov/9255249/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Methotrexate therapy in psoriasis].

Methotrexate is a good treatment for severe psoriasis. Low-dose, once a week treatment is safe if guidelines are followed. Hematologic toxicity occurs especially if other drugs are associated. Hepatic cumulative toxicity is the main limiting factor for use. Compared with other systemic treatments of psoriasis, the low cost, efficiency and well known adverse effects, are still favorable to methotrexate.

Dermatologic Agents↗

[Successful treatment of skin and lung sarcoidosis with fumaric acid ester].

A 61-year old female patient with cutaneous sarcoidosis was treated with fumaric acid esters (Fumaderm). After 12 months of therapy, lesions were markedly improved and treatment was discontinued. 18 months later, the cutaneous lesions recurred, angiotensin converting enzyme (ACE) serum levels were increased and a chest X-ray demonstrated pulmonary involvement. Therapy with fumaric acid esters was again started. The skin showed improvement after 2 months and completely cleared within 17 months, within 4 months ACE levels normalized, and within 10 months radiologic changes markedly resolved. This case demonstrates a possible role for fumaric acid esters not only in the treatment of cutaneous but also systemic sarcoidosis.

Dermatologic Agents↗